Abrilada 40 mg / 0.8 ml, Injektionslösung im Fertigpen
7680678310019
CH-67831
Injektionslösung im Fertigpen
Associated product:
ABRILADA sol inj 40 mg/0.8ml stylo pré 0.8 ml
1 / 2
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Injektor(en), vorgefüllt/Pen
- Galenic form
- Injektionslösung im Fertigpen
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
adalimumabum
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
natrium
|
5.0 UG | Substance | HBESI |
|
saccharum
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 419.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2021
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 67831
- Drug name
- Abrilada, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- L04AB04
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 02/12/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ABRILADA sol inj 40 mg/0.8ml stylo pré 0.8 ml
- Description (DE)
- ABRILADA Inj Lös 40 mg/0.8ml Fertpen 0.8 ml
- Market launch
- 02/12/2020
- Narcotic (BTM)
- No
Other package sizes (3)
ABRILADA sol inj 40 mg/0.8ml stylo pré 2 x 0.8 ml
2 INJ
GTIN: 7680678310026
None
4 INJ
GTIN: None
None
6 INJ
GTIN: None